These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9639306)

  • 1. Comparison of the kit performance of three 99mTc myocardial perfusion agents.
    Cagnolini A; Whitener D; Jurisson S
    Nucl Med Biol; 1998 May; 25(4):435-9. PubMed ID: 9639306
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
    Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
    J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of a two-components lyophilized kit for Tc-sestamibi: transchelation preparation of Tc-99m-sestamibi.
    Pandey PM; Sachdev SS; Ramamoorthy N; Lal R; Ranganatha DK; Narasimhan S; Oommen R; Gunasekaran S; Nair NA
    Nucl Med Biol; 1997 Oct; 24(7):697-700. PubMed ID: 9352543
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial perfusion scintigraphy.
    Prvulovich E
    Clin Med (Lond); 2006; 6(3):263-6. PubMed ID: 16826859
    [No Abstract]   [Full Text] [Related]  

  • 6. The growing flood of technetium-99m myocardial perfusion agents. More water ... or more mud?
    Miller DD
    Circulation; 1995 Jan; 91(2):555-8. PubMed ID: 7805263
    [No Abstract]   [Full Text] [Related]  

  • 7. Discordant results in Tc-99m tetrofosmin and Tc-99m sestamibi parathyroid scintigraphies.
    Duarte PS; Domingues FC; Costa MS; Brandão C; Oliveira MA; Vieira JG
    Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1166-8. PubMed ID: 18157394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial kinetics of (201)Thallium, (99m)Tc-tetrofosmin, and (99m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart.
    Fukushima K; Momose M; Kondo C; Kusakabe K; Kasanuki H
    Ann Nucl Med; 2007 Jul; 21(5):267-73. PubMed ID: 17634844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of background correction in the estimation of myocardial uptake of 99mTc labelled perfusion imaging agents.
    Smith T; Raval U; Lahiri A
    Phys Med Biol; 1998 Sep; 43(9):2695-702. PubMed ID: 9755956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial kinetics of 99m technetium-Q agents: studies in isolated cardiac myocyte, isolated perfused rat heart, and canine regional myocardial ischemia models.
    McGoron AJ; Biniakiewicz D; Millard RW; Kumar A; Kennedy SC; Roszell NJ; Gabel M; Huth C; Walsh RA; Gerson MC
    Invest Radiol; 1999 Nov; 34(11):704-17. PubMed ID: 10548383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
    Giordano A; Meduri G
    Eur J Nucl Med; 1997 Mar; 24(3):347. PubMed ID: 9143476
    [No Abstract]   [Full Text] [Related]  

  • 12. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
    McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
    Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial perfusion imaging with 99mTc-labeled radiopharmaceuticals: How fast can a stress-rest same-day imaging protocol be completed?
    Taillefer R
    J Nucl Cardiol; 2017 Aug; 24(4):1328-1331. PubMed ID: 27044387
    [No Abstract]   [Full Text] [Related]  

  • 14. Formulation of 99mTc-Sn-EDTMP: freeze-dried kit for bone scanning.
    Mushtaq A
    Nucl Med Biol; 1998 Apr; 25(3):313-5. PubMed ID: 9620638
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells.
    Nakamura K; Sammiya T; Hashimoto J; Ishibashi R; Matsumoto K; Kubo A
    Ann Nucl Med; 1996 Nov; 10(4):375-81. PubMed ID: 9006721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial perfusion imaging].
    Matsunari I
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():317-22. PubMed ID: 12734991
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection.
    Gremillet E; Champailler A
    Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute radionuclide perfusion imaging for evaluation of chest pain in the emergency department: need for a large clinical trial.
    Beller GA
    J Nucl Cardiol; 1996; 3(6 Pt 1):546-9. PubMed ID: 8989678
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agents.
    Gerundini P; Savi A; Gilardi MC; Margonato A; Vicedomini G; Zecca L; Hirth W; Libson K; Bhatia JC; Fazio F
    J Nucl Med; 1986 Mar; 27(3):409-16. PubMed ID: 3754889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi).
    Hung JC; Wilson ME; Brown ML; Gibbons RJ
    J Nucl Med; 1991 Nov; 32(11):2162-8. PubMed ID: 1834815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.